New hope for tough lung cancer: targeted drug shows promise in Late-Stage trial
NCT ID NCT06502977
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study tests a drug called tarlatamab in 32 Chinese adults with advanced small cell lung cancer that has worsened after at least two prior treatments. The main goal is to see if the drug can shrink tumors. This is a Phase 2 trial, meaning it's still being tested for safety and effectiveness, and is not a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE-STAGE SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Army Special Medical Center of Peoples Liberation Army
Chongqing, Chongqing Municipality, 400042, China
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Fujian Cancer Hospital
Fuzhou, 350011, China
-
Harbin Meidical University Cancer Hospital
Harbin, Heilongjiang, 150000, China
-
Jiangmen Central Hospital
Jiangmen, Guangdong, 529000, China
-
Mengchao Hepatobiliary Hospital of Fujian Medical University
Fuzhou, Fujian, 350025, China
-
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
Taizhou Hospital of Zhejiang Province
Linhai, Zhejiang, 317000, China
-
The Second Affiliated Hospital of Army Medical University, People's Liberation Army
Chongqing, Chongqing Municipality, 400037, China
-
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
-
Tianjin Medical University General Hospital
Tianjin, Tianjin Municipality, 300052, China
-
Tongji Hospital Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, 430030, China
Conditions
Explore the condition pages connected to this study.